Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Ocular Hypertension Treatment Study: 20 yr quality of life (QoL) outcomes
Author Affiliations & Notes
  • Mae O Gordon
    Ophthalmology and Visual Sciences, Biostatistics, Washington University in St Louis, St Louis, Missouri, United States
  • Feng Gao
    Public Health Services, Washington University in St Louis, St Louis, Missouri, United States
  • Michael A Kass
    Ophthalmology and Visual Sciences, Washington University in St Louis, St Louis, Missouri, United States
  • Julia Huecker
    Ophthalmology and Visual Sciences, Biostatistics, Washington University in St Louis, St Louis, Missouri, United States
  • Pradeep Y Ramulu
    Wilmer Eye Institute, Johns Hopkins Medicine, Baltimore, Maryland, United States
  • Stuart Keith Gardiner
    Legacy Devers Eye Institute at Legacy Good Samaritan Medical Center, Portland, Oregon, United States
  • Linda M Zangwill
    University of California San Diego, La Jolla, California, United States
  • Footnotes
    Commercial Relationships   Mae Gordon Perfuse Therapeutics, Code F (Financial Support); Feng Gao None; Michael Kass None; Julia Huecker None; Pradeep Ramulu None; Stuart Gardiner None; Linda Zangwill None
  • Footnotes
    Support  NIH grants: EY025180, EY025181, EY025182, EY025183, EY002687, TR002345, unrestricted grant from Research to Prevent Blindness
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4622. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mae O Gordon, Feng Gao, Michael A Kass, Julia Huecker, Pradeep Y Ramulu, Stuart Keith Gardiner, Linda M Zangwill; Ocular Hypertension Treatment Study: 20 yr quality of life (QoL) outcomes. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4622.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To describe QoL in participants who did/did not develop POAG

Methods : National Eye Institute Vision Function Questionnaire-25 (VFQ) and Glaucoma Quality of Life 15 item survey (GQL) were administered at the 20 year follow-up visit which included IOP, Humphrey 24-2 visual fields (VF), Pelli-Robson contrast sensitivity (CS), and ETDRS visual acuity (VA). POAG was defined as reproducible VF loss or reproducible clinically significant optic disc deterioration as determined by masked graders at Reading Centers and attributed to glaucoma by a masked Endpoint Committee. Rasch calibrated total scores were estimated for both VFQ and GQL. The scores were rescaled as 0 to 100, with higher values indicating better QoL. Linear regressions were used to assess their association with clinical and demographic characteristics. Participants who did not develop POAG serve as the reference group. Participants who developed POAG were divided into 4 mutually exclusive groups: optic disc POAG (unilateral or bilateral) and visual field POAG (unilateral or bilateral).

Results : 80% of known survivors (679/843) completed examination and VFQ and/or GQL. Median follow-up was 22 years, mean age 74+8 SD years, 25% African ancestry, and 61% female. 53% (358/679) did not develop POAG. Among participants who developed POAG (n=321), 28% were unilateral disc POAG, 19% bilateral optic disc POAG, 33% unilateral VF POAG and 20% bilateral VF POAG. Table 1 reports Rasch calibrated scores for these groups.

In univariate analyses, VFQ scores in both unilateral and bilateral disc POAG groups did not differ from No POAG group (p=0.92 and p=0.64 respectively). VFQ scores in both unilateral and bilateral VF POAG groups were lower than the No POAG group (p=0.033 and p=0.001 respectively). Factors predictive of VFQ in multivariable analyses included bilateral VF POAG, MD, CS, VA, sex, number of systemic comorbidities and treatment/surgery for ocular diseases other than glaucoma (Table 2). Profile of factors was similar for GQL except that CS was not selected (Table 2).

Conclusions : QoL in participants who developed preperimetric POAG in one or both eyes did not differ from age-similar participants who did not develop POAG. QoL was lowest in participants who developed bilateral VF loss even after statistical adjustment for mean deviation and other vision-specific factors.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×